New heart valve registry aims to improve aortic stenosis treatment
NCT ID NCT06818435
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry will follow 150 people in Portugal who receive the Myval heart valve through a minimally invasive procedure called TAVI. The goal is to see how safe and effective the valve is for treating severe aortic stenosis. Researchers will track complications like death, stroke, kidney injury, and bleeding over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Myval THV series (a replacement heart valve implanted via a catheter)
What this could lead to
If successful, this registry could confirm that the Myval valve is a safe and effective option for treating severe aortic stenosis without open-heart surgery.
What could go wrong
This is an observational registry, not a controlled trial, so results may be less definitive. Risks include serious complications like stroke, bleeding, or need for a pacemaker.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unidade Local de Saúde Alentejo Central E.P.E. - Hospital Espírito Santo
RECRUITINGEvora, 7000-811, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unidade Local de Saúde de Coimbra
RECRUITINGCoimbra, 3004-561, Portugal
Contact Email: •••••@•••••
-
Unidade Local de Saúde de Santa Maria, E.P.E. - Hospital de Santa Maria
RECRUITINGLisbon, 1649-035, Portugal
Contact Email: •••••@•••••
-
Unidade Local de Saúde de São José E.P.E. - Hospital Santa Marta
NOT_YET_RECRUITINGLisbon, 1169-024, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unidade Local de Saúde do Lisboa Ocidental E.P.E. - Hospital Santa Cruz
RECRUITINGCarnaxide, 2790-134, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unidade Local de São João E.P.E.
NOT_YET_RECRUITINGPorto, 4200-319, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••